Real-world monitoring of platelet counts among patients with epithelial ovarian cancer receiving first-line maintenance niraparib in the United States: the ACTIV1ZE study

被引：0
|
作者：
Musa, Fernanda [1 ]
Boyle, Tirza [2 ]
Lim, Jonathan [2 ]
Moore, Julia [2 ]
Schilder, Jeanne [3 ]
Hurteau, Jean [4 ]
Golembesky, Amanda [5 ]
Landrum, Lisa [6 ]
机构：
[1] Swedish Canc Inst, Seattle, WA USA
[2] GSK, Upper Providence, PA USA
[3] GSK, Philadelphia, PA USA
[4] GSK, Waltham, MA USA
[5] GSK, Durham, NC USA
[6] Indiana Univ, Hlth Simon Canc Ctr, Indianapolis, IN USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.74
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PR032/#594
引用
收藏
页码：A56 / A57
页数：2
相关论文
共 50 条
  • [31] Real-world data from a multi-center study: Insights to the efficacy and safety in patients with ovarian cancer (OC) received niraparib as first-line (1st-L) maintenance therapy (MT)
    Zhao, Minmin
    Shen, Yang
    Zhou, Ying
    Chen, Bingwei
    Wu, Xin
    Miao, Pengcheng
    Jiang, Zhi
    Zhu, Tao
    Xu, Xizhong
    Zhang, Bei
    Yuan, Donglan
    Zhang, Yang
    Sun, Wei
    He, Aiqin
    Zhao, Min
    Hou, Wenjie
    Shao, Zhuyan
    Jia, Meiqun
    Zhu, Yanling
    Chen, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] Real-world BRCA1/2 and homologous recombination deficiency testing dynamics and time to treatment discontinuation on PARP inhibitor first-line maintenance among patients with epithelial ovarian cancer
    Previs, Rebecca
    Roos, Alison
    Vasudevan, Anupama
    Blanc, Simon
    Schnettler, Erica
    Craver, Christopher
    Severson, Eric
    Sathyan, Pratheesh
    Varughese, Prateesh
    Ramkissoon, Shakti
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S174 - S175
  • [33] Examining real-world treatment benefits of first-line maintenance niraparib in non-BRCA mutant high grade serous ovarian cancers
    Hannaway, Nicola
    Kassaris, Stefania
    Davies, Janine
    Smrke, Alannah
    Tinker, Anna
    Drew, Yvette
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A178 - A178
  • [34] Real-world treatment patterns in recurrent or advanced endometrial cancer patients on first-line systemic therapy in the United States
    Ogando, Yoscar M.
    Chen, Lei
    Zhang, Jingchuan
    Kelkar, Sneha S.
    Prabhu, Vimalanand S.
    Miles, Nicola
    Green, Angela
    Makker, Vicky
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 233 - 234
  • [35] Real-world outcomes of niraparib treatment in patients with ovarian cancer: The first observational multicenter study in China.
    Li, Jin
    Wu, Xiaohua
    Shou, Huafeng
    Zheng, Fei
    Huang, Xiaohong
    Liu, Fang
    Tang, Xuedong
    Yang, Jianhua
    Zhang, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17614 - E17614
  • [36] Real-world prescribing patterns for first-line and maintenance treatment of patients with advanced urothelial cancer (UC)
    Inderjeeth, Andrisha-Jade
    O'haire, Sophie
    Gibbs, Peter
    Wong, Lih-Ming
    Zhang, Alison
    Manohar, Paul
    James, Lynam
    Sengupta, Shomik
    Wong, Shirley
    Weickhardt, Andrew
    Tran, Ben
    Conduit, Ciara
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 95 - 95
  • [37] DISEASE PROGRESSION IN PATIENTS WITH OVARIAN CANCER WHO RECEIVED FIRST-LINE MAINTENANCE THERAPY OR ACTIVE SURVEILLANCE, A US REAL-WORLD ANALYSIS
    Chase, D.
    Perhanidis, J. A.
    Gupta, D.
    Kalilani, L.
    Woodward, T.
    Gonzalez-Martin, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A266 - A267
  • [38] Poly (adenosine diphosphate [ADP]-ribose) polymerase inhibitor first-line maintenance among patients with newly diagnosed advanced ovarian cancer in a real-world database
    Liu, Jinan
    Chan, John
    Song, Jinlin
    Kalilani, Linda
    Yang, Karen
    Wu, Eric
    Hurteau, Jean
    Thaker, Premal
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S179 - S180
  • [39] Patient characteristics, treatment patterns and real-world effectiveness of niraparib in France: an ESME retrospective study in recurrent ovarian cancer patients treated with niraparib maintenance
    Gladieff, Laurence
    Macouillard, Pauline
    Toussaint, Philippe
    El-Mouaddin, Nadia
    Jacquemin, Virginie
    Fages, Anne
    Nachbaur, Gaelle
    Gourgou, Sophie
    Pomel, Christophe
    Colombo, Pierre-Emmanuel
    Bosquet, Lise
    Rodrigues, Manuel
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A307 - A308
  • [40] Real-World Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Receiving First-Line (1L) Therapy in the United States (US)
    Mato, Anthony R.
    Ravelo, Arliene
    MyTo, Tu
    Schuldt, Robert
    Biondo, Juliana M. L.
    BLOOD, 2021, 138
12345